at Benzinga.com (Dec 30, 2014)
Dendreon (DNDN) +6.9% - although down from earlier highs - on rumors it might be trying to sell itself, with Celgene (CELG -0.2%) one name being mooted. Feeding the speculation beast is new CEO John Johnson working from New Jersey even though the company is based in Seattle.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Nov 18, 2014)
at Zacks.com (Nov 11, 2014)
at CNBC.com (Nov 10, 2014)
at Zacks.com (Nov 10, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs